동향
전체 8345
  • Advances in Uterine Leiomyoma Research (Day 1)
    • - National Institutes of Health (U.S.). Office of Research on Women's Health. (2010/03/04)
    • - Category : Women's Health

    Advances in Uterine Leiomyoma Research (Day 1)

  • Human Mycobacterial Infections: Probes of Innate and Acquired Immunity
    • - Holland, Steven M.
      National Institutes of Health (U.S.) (2010/03/04)
    • - Category : Immunology

    Human Mycobacterial Infections: Probes of Innate and Acquired Immunity

  • Aquaporin Water Channels: Atomic Structure to Clinical Medicine
    • - Peter Agre, Ph.D., Johns Hopkins University School of Medicine (2010/03/04)
    • - Category : Wednesday Afternoon Lectures
    The high water permeability of certain biological membranes is due to the presence of aquaporin water channel proteins. AQP1 was discovered in human red cells. AQP1 has been thoroughly characterized biophysically, and the atomic structure of AQP1 has been elucidated. Ten homologs have been identified in humans. These are selectively permeated by water (aquaporins) or water plus glycerol (aquaglyceroporins). The sites of expression predict the clinical phenotypes in humans. Individuals lacking Colton blood group antigens have mutations in the AQP1 gene. When deprived of water, AQP1-null individuals exhibit a defect in urine concentration and a marked reduction in fluid exchange between capillary and interstitium in lung.

    For more information, visit
    http://biolchem.bs.jhmi.edu/members/agre.htm

    NIH Director's Wednesday Afternoon Lecture Series

    Aquaporin Water Channels: Atomic Structure to Clinical Medicine

  • Wildpackets Training for Omnipliance
    • - DNST (2010/03/04)
    • - Category : NIH Only

    Wildpackets Training for Omnipliance

  • Phosphoinositide 3-Kinase Pathway and Human Disease
    • - Lewis Cantley, Ph.D., Harvard Institutes of Medicine (2010/03/04)
    • - Category : Wednesday Afternoon Lectures
    Phosphoinositide 3-kinase (PI3K) is activated by a host of hormones and growth factors and produces membrane bound lipid second messengers that are implicated in complex cellular events such as cell survival, cell growth, cell cycle entry and chemotaxis, based on ex-vivo experiments. We have used a variety of approaches to map protein kinase pathways upstream and downstream of PI3K. In addition, we have manipulated genes in the mouse to assess the role of PI3K and downstream responses in normal development, in insulin signaling and in cancers. These studies have revealed a tightly regulated and highly conserved signaling network, perturbations of which can result in a wide variety of diseases, including cancers, tuberous sclerosis and type 2 diabetes.

    For more information, visit
    http://www.fas.harvard.edu/%7Ebiophys/Lewis_Cantley.htm

    WALS

    Phosphoinositide 3-Kinase Pathway and Human Disease

  • Screen Issues: Taming the Electronic Monsters in Your Home
    • - The NIH Work/Life Center (WLC) (2010/03/04)
    • - Category : Work/Life Center
    Many kids, given the opportunity, would spend hours in front of a screen - either on the computer, playing games or instant messaging friends, battling video games, or passively watching television. Because they won't set their own limits, parents need to do the job. Learn how to bring these monsters under control.

    The NIH Work/Life Center (WLC), in cooperation with the NIH Employee Assistance Program, presents the ???Faces & Phases of Life??? seminar series for 2005.

    For more information, visit
    http://wlc.od.nih.gov/faces.asp

    Screen Issues: Taming the Electronic Monsters in Your Home

  • Great Teachers - An Internist Encounters Addiction
    • - Samet, Jeffrey H.
      National Institutes of Health (U.S.) (2010/03/04)
    • - Category : Clinical Center Grand Rounds

    Great Teachers - An Internist Encounters Addiction

  • Demystifying Medicine - Fevers, Genes and History: Adventures in Genomics of Inflammation
    • - Dan Kastner, NIAMS and Rafaella Goldbach-Mansky, NIAMS (2010/03/04)
    • - Category : Demystifying Medicine
    The course includes presentation of patients, pathology, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students, fellows, and staff, it is also of interest to medical students and clinicians. The course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components which are presented by NIH staff and outside invitees.

    For more information, visit
    http://www1.od.nih.gov/oir/DemystifyingMed/index.html

    Demystifying Medicine - Fevers, Genes and History: Adventures in Genomics of Inflammation

  • State-Dependence of Hippocampal Synaptic Plasticity
    • - Madison, Daniel.
      National Institutes of Health (U.S.) (2010/03/04)
    • - Category : Neuroscience

    State-Dependence of Hippocampal Synaptic Plasticity

  • Proteomic Approaches to Study Signal Transduction Pathways
    • - Pandey, Akhilesh.
      National Institutes of Health (U.S.) (2010/03/04)
    • - Category : Proteomics

    Proteomic Approaches to Study Signal Transduction Pathways

  • Chemical Warfare Agents: an EPically BIG Overview
    • - Madsen, James M.
      National Institutes of Health (U.S.) (2010/03/04)
    • - Category : Emergency Preparedness and Biodefense

    Chemical Warfare Agents: an EPically BIG Overview

  • Human Cancer Immunotherapy Based on Overcoming Negative Immunoregulatory Signals
    • - Rosenberg, Steven A.
      National Institutes of Health (U.S.) (2010/03/04)
    • - Category : Immunology

    Human Cancer Immunotherapy Based on Overcoming Negative Immunoregulatory Signals

  • All Hands Meeting (NIH Only)
    • - Zerhouni, Elias A.
      National Institutes of Health (U.S.) (2010/03/04)
    • - Category : NIH Only

    All Hands Meeting (NIH Only)

  • When a Patient Requests to Alter Records, What is the Appropriate Response?
    • - Annas, George J.
      National Institutes of Health (U.S.) (2010/03/04)
    • - Category : Clinical Center Grand Rounds

    When a Patient Requests to Alter Records, What is the Appropriate Response?

  • Human Genetic Variation and Common Disease: A Short-Term Approach for Improving Human Health
    • - David R. Cox, M.D., Ph.D., Perlagen Sciences, Inc. (2010/03/04)
    • - Category : Wednesday Afternoon Lectures
    Common human diseases such, as cardiovascular disease and psychiatric illness, are caused by a combination of multiple genetic and environmental factors. The bounded nature of the human genome, and the availability of the complete human genome sequence, have resulted in extensive efforts to define the genetic basis of a wide variety of complex human traits. One approach for identifying such genetic risk factors is the case-control association study, in which a group of individuals with disease is found to have an increased frequency of a particular genetic variant compared to a group of control individuals. We have identified a number of genetic risk factors by using such association studies.

    For more information, visit
    http://www.chimolecularmed.com/speakers/cox.asp

    NIH Director's Wednesday Afternoon Lecture Series

    Human Genetic Variation and Common Disease: A Short-Term Approach for Improving Human Health

  • Can the Angiogenic Switch be Prevented in Human Cancer? (NIH-Only)
    • - Judah Folkman, M.D., Children's Hospital Boston (2010/03/04)
    • - Category : NCI CCR Grand Rounds (NIH Only)
    Center for Cancer Research - National Cancer Institute Grand Rounds

    The primary educational objective of these seminars is to provide new information, ideas, and discussion about timely areas of research with impact on the field of oncology. A secondary educational objective is to elicit participation by individuals from all divisions of the intramural NCI, and thus facilitate more interactions among investigators and groups in the NCI.

    Please note - CCRNCI lectures are not archived and are available for viewing in real time only.

    Can the Angiogenic Switch be Prevented in Human Cancer? (NIH-Only)

  • Women's Health Interdisciplinary Research Symposium (Day 2)
    • - Office of Research on Women's Health (2010/03/04)
    • - Category : Women's Health
    Featuring the research of program scholars and researchers from two Office of Research on Women's Health (ORWH) programs: Building Interdisciplinary Research Careers in Women's Health (BIRCWH) and Specialized Centers of Research on Sex and Gender Factors Affecting Women's Health (SCOR). Topics to be discussed: Antiretrovirals/HIV; Perinatology/Cardiovascular Risk Factors; Reproductive Health; Substance Abuse; Stress/Pain.

    For more information, visit
    http://www.orwhmeetings.com

    Women's Health Interdisciplinary Research Symposium (Day 2)

  • Dietary Supplements: What Do You Know? What Should You Know?
    • - Coates, Paul M.
      National Institutes of Health (U.S.) (2010/03/04)
    • - Category : Medicine for the Public

    Dietary Supplements: What Do You Know? What Should You Know?

  • Is This Normal? Healthy Development vs. Warning Signs in Tweens and Teens
    • - The NIH Work/Life Center (WLC) (2010/03/04)
    • - Category : Work/Life Center
    The key to effectively dealing with the challenges of adolescence is to have a good sense of what behaviors and attitudes are healthy and normal and which ones are ???out-of-bounds???. Thankfully, there is ample research and experience to draw upon to guide parents and professionals through this challenging period

    The NIH Work/Life Center (WLC), in cooperation with the NIH Employee Assistance Program, presents the seventh annual ???Faces & Phases of Life??? seminar series for fall 2004.

    For more information, visit
    http://wlc.od.nih.gov/faces.asp

    Is This Normal? Healthy Development vs. Warning Signs in Tweens and Teens

  • Celebrating Julie - Honors the Life and Science of NIMH's Julius Axelrod
    • - Hosted by NIMH (2010/03/04)
    • - Category : Conferences
    Celebrating Julie, an event to honor the life and achievements of National Institutes of Health scientist and Nobel Laureate Julius Axelrod (1912-2004). NIH Director Elias Zerhouni, M.D., and NIMH Director Thomas Insel, M.D., will host prot챕g챕s, colleagues and friends for a day of scientific reflection on Dr. Axelrod???s discoveries in his long and successful career. Dr. Axelrod spent the majority of his 50 years as a researcher at NIMH.

    For more information, visit
    http://www.nimh.nih.gov/press/axelrodsymposiumprogram.pdf

    Celebrating Julie - Honors the Life and Science of NIMH's Julius Axelrod